NCT02422147Completed
EUS-guided Ablation of Pancreatic Cyst Neoplasms
Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cyst Neoplasms
Source: ClinicalTrials.gov · Last updated 17 Dec 2024
Brief summary (registry, in English)
This is a registry that will maintain prospective data on the clinical outcomes of all patients with pancreatic cyst lesions who undergo EUS-guided alcohol ablation.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 24 Feb 2015
- Start date
- 1 Jun 2016
- Primary completion date
- 12 Dec 2024
- Lead sponsor
- AdventHealth
- Diseases
- Pancreatic cancer
- NCT number
- NCT02422147
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Jun 2016 to the primary completion date, 12 Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cysts with hypoechoic mass lesions that on fine needle aspiration (FNA)reveal malignant cells.
- Recent history of pancreatitis and EUS findings suggestive of a pseudocyst.
Lab values
- Bleeding tendency; international normalized ratio (INR) \>1.4 or platelet count \<70,000.
Other
- Cysts measuring \<2cm or \>4cm.
- Multiloculated cysts (\>4 locules).
- Cysts with vascular supply.
- Cysts communicating with the main pancreatic duct via an obvious side-branch measuring 2mm or more in diameter.
Who the study is looking for
- Benign branch-duct intraductal papillary mucinous neoplasm (IPMN) or mucinous cyst neoplasm (MCN) measuring \>2 and up to 4cm in size and located in the head or body of the pancreas.
- Benign branch-duct IPMN or MCN measuring \> 2 and up to 4cm in size and located in the tail of the pancreas in a high-risk surgical candidate.
- A branch-duct IPMN or MCN with high-risk features (mural nodule or enlarging in size) in a high-risk surgical patient.
- Indeterminate cyst lesions
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AdventHealth Coordinator of this site? Confirm its status | Orlando | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.